We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,357
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Stride
LRN
$3.43B
| $1.28M | ﹤0.01% |
62,834
+539
| +0.9% | +$11.5K |
|
1977
MBIA
MBI
$272M
| $1.27M | ﹤0.01% |
137,028
-1,122
| -0.8% | -$10.7K |
|
1978
Fossil Group
FOSL
$345M
| $1.27M | ﹤0.01% |
160,926
+9,118
| +6% | +$84.1K |
|
1979
Liberty Media Series A
FWONA
$22.7B
| $1.25M | ﹤0.01% |
29,933
+141
| +0.5% | +$5.54K |
|
1980
Kforce
KFRC
$1.05B
| $1.25M | ﹤0.01% |
31,563
-40
| -0.1% | -$1.58K |
|
|
PRNB
1981
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $1.25M | ﹤0.01% |
22,846
+8,302
| +57% | +$310K |
|
|
QUOT
1982
DELISTED
Quotient Technology Inc
QUOT
| $1.25M | ﹤0.01% |
126,849
+1,599
| +1% | +$15.3K |
|
1983
Independent Bank Corp
IBCP
$789M
| $1.24M | ﹤0.01% |
54,895
+291
| +0.5% | +$6.44K |
|
1984
Haverty Furniture Companies
HVT
$450M
| $1.24M | ﹤0.01% |
61,462
+2,529
| +4% | +$51.1K |
|
1985
Movado Group
MOV
$844M
| $1.24M | ﹤0.01% |
57,001
+2,555
| +5% | +$59.8K |
|
1986
CareDx
CDNA
$2.34B
| $1.23M | ﹤0.01% |
57,078
+2,302
| +4% | +$52.8K |
|
|
EVRI
1987
DELISTED
Everi Holdings
EVRI
| $1.22M | ﹤0.01% |
90,976
+1,611
| +2% | +$18.4K |
|
1988
Central Garden & Pet Co
CENT
$2.82B
| $1.22M | ﹤0.01% |
49,080
+2,206
| +5% | +$52.5K |
|
1989
Federal Agricultural Mortgage
AGM
$2.57B
| $1.22M | ﹤0.01% |
14,583
+196
| +1% | +$16.3K |
|
1990
Great Southern Bancorp
GSBC
$881M
| $1.22M | ﹤0.01% |
19,228
+90
| +0.5% | +$5.45K |
|
|
PEI
1991
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $1.22M | ﹤0.01% |
15,235
+900
| +6% | +$75K |
|
1992
WillScot Mobile Mini Holdings
WSC
$4.71B
| $1.22M | ﹤0.01% |
65,826
+2,602
| +4% | +$43.7K |
|
|
LDL
1993
DELISTED
Lydall, Inc.
LDL
| $1.22M | ﹤0.01% |
59,197
+2,808
| +5% | +$58.1K |
|
|
VSTO
1994
DELISTED
Vista Outdoor Inc.
VSTO
| $1.21M | ﹤0.01% |
162,302
+8,873
| +6% | +$66.6K |
|
|
NSTG
1995
DELISTED
NanoString Technologies, Inc.
NSTG
| $1.21M | ﹤0.01% |
43,484
+1,269
| +3% | +$30.8K |
|
1996
Community Trust Bancorp
CTBI
$1.43B
| $1.21M | ﹤0.01% |
25,883
+114
| +0.4% | +$5.05K |
|
|
FFIC
1997
DELISTED
Flushing Financial
FFIC
| $1.21M | ﹤0.01% |
55,832
+222
| +0.4% | +$4.72K |
|
1998
Clearwater Paper
CLW
$366M
| $1.21M | ﹤0.01% |
56,413
+2,539
| +5% | +$51K |
|
|
GTHX
1999
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $1.2M | ﹤0.01% |
45,524
-315
| -0.7% | -$7.37K |
|
2000
Tidewater
TDW
$4.08B
| $1.2M | ﹤0.01% |
62,176
+1,806
| +3% | +$28.8K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.